Skip to main content
C

Cryofocus Medtech (Shanghai) Co., Ltd. — Investor Relations & Filings

Ticker · 6922 HKEX Manufacturing
Open in API
Filings indexed 145 across all filing types
Latest filing 2026-01-30 Share Issue/Capital Cha…
Country HK Hong Kong
Listing HKEX 6922

About Cryofocus Medtech (Shanghai) Co., Ltd.

http://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co., Ltd. is a medical device company specializing in the research, development, and production of innovative cryoablation systems. The company utilizes self-developed cryotherapy technology primarily in the fields of vascular interventional therapy and procedures via natural cavities. Key products include cryoablation systems designed for the treatment of major diseases such as atrial fibrillation, refractory hypertension, and bladder cancer. Additionally, the product portfolio encompasses surgical consumables and novel endoscopic clips used in digestive tract endoscopic surgery. The company holds independent intellectual property rights for its innovative devices.

Recent filings

Filing Released Lang Actions
COMPLETION OF THE SUBSCRIPTION AGREEMENT A AND TERMINATION OF THE SUBSCRIPTION AGREEMENT B
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from Cryofocus Medtech (Shanghai) Co., Ltd. regarding the completion of a share subscription agreement (Subscription Agreement A) and the termination of another (Subscription Agreement B). It details the issuance of new shares, the impact on the shareholding structure, and the use of proceeds. This falls under the category of capital changes and share issuance, which is best classified as 'SHA' (Share Issue/Capital Change).
2026-01-30 English
SUBSCRIPTIONS OF NEW H SHARES UNDER GENERAL MANDATE
Share Issue/Capital Change Classification · 1% confidence The document is an official announcement from Cryofocus Medtech (Shanghai) Co., Ltd. regarding the subscription of new H shares under a general mandate. It details the terms of the subscription agreements, the number of shares, the subscription price, the use of proceeds, and the impact on the shareholding structure. This type of corporate action, involving the issuance of new shares to raise capital, falls under the 'Share Issue/Capital Change' category.
2026-01-12 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for companies listed on the HKEX to report monthly movements in their securities, including share capital and issued shares. Since it details changes in capital structure and share issuance, it falls under the category of share capital changes. Among the provided options, 'SHA' (Share Issue/Capital Change) is the most accurate classification for this type of regulatory filing.
2026-01-07 English
VOLUNTARY ANNOUNCEMENT NMPA APPROVAL FOR ANTI-GASTROESOPHAGEAL REFLUX SYSTEM
Regulatory Filings Classification · 1% confidence The document is a voluntary announcement by Cryofocus Medtech (Shanghai) Co., Ltd. regarding the NMPA approval of a new medical device (Anti-Gastroesophageal Reflux System). It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate regulatory announcement regarding business development, it falls under the fallback category of Regulatory Filings (RNS).
2025-12-16 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2025
Share Issue/Capital Change Classification · 1% confidence The document is a 'Monthly Return for Equity Issuer' (Form FF301) filed with the Hong Kong Stock Exchange (HKEX). This form is a standard regulatory requirement for listed companies in Hong Kong to report monthly movements in securities, share capital, and treasury shares. Since it details changes in share capital and securities, it falls under the category of share issues and capital changes.
2025-12-02 English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2025
Regulatory Filings Classification · 1% confidence The document is a standard Hong Kong Stock Exchange (HKEX) Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts under Chapter 19B”. It provides a routine monthly update on authorised/registered share capital and movements in issued shares. This is a regulatory submission to HKEX rather than an earnings release, annual report, proxy statement, or management discussion. It does not announce a specific capital transaction but fulfills Listing Rule reporting obligations. As such it falls under the “Regulatory Filings” fallback category (RNS).
2025-11-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.